Effects of Oropharyngeal Exercises on Patients With Primary Snore, Mild and Moderate Obstructive

NCT ID: NCT01636856

Last Updated: 2014-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized study of patients with primary snore, mild and moderate obstructive sleep apnea. Protocol include 40 patients randomized to oropharyngeal exercise or use of nasal dilator, breathing exercise and nasal lavage. The objectives are study the effects of therapy on oropharyngeal in a series of clinical and physiologic and anatomic variables, changes on snore and quality of sleep using Pharyngeal Critical Pressure, Magnetic Resonance, Negative expiratory pressure and snore analyses. Hypothesis that the therapy group (oropharyngeal exercises) will have more modifications compared to the control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is randomized study with multiple primary endpoints. In December 2012 the study also started collecting tongue strength and endurance (IOPI). Because not all patients are able to perform all evaluations, the publications will be divided and presented according to the completion of the required number of patients for each primary endpoint.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Snore, Obstructive Sleep Apnea (Mild and Moderate).

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Oropharyngeal exercises and oropharyngeal functions

Group Type ACTIVE_COMPARATOR

Oropharyngeal exercises

Intervention Type BEHAVIORAL

Oropharyngeal exercises (derived from speech language pathology) to the soft palate, tongue and facial muscles exercises as well as stomatognathic functions.

2

Nasal dilator, respiratory exercise, nasal lavage

Group Type SHAM_COMPARATOR

Respiratory exercises, nasal dilator, nasal lavage

Intervention Type BEHAVIORAL

Respiratory exercises, nasal dilator, nasal lavage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oropharyngeal exercises

Oropharyngeal exercises (derived from speech language pathology) to the soft palate, tongue and facial muscles exercises as well as stomatognathic functions.

Intervention Type BEHAVIORAL

Respiratory exercises, nasal dilator, nasal lavage

Respiratory exercises, nasal dilator, nasal lavage

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

subjects with primary snore, mild and moderate obstructive sleep apnea

Exclusion Criteria

BMI \> or = 40, craniofacial malformations, smokers, pregnant women, edentulous, total dental prostheses, use of hypnotic medications, stroke, neuromuscular dystrophy, coronary artery disease, chronic heart failure, chronic obstructive pulmonary disease, severe nasal obstructive disease, pharyngeal surgery,already made some kind of treatment for obstructive sleep apnea.
Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo

OTHER

Sponsor Role lead

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

Sponsor Role collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Geraldo Lorenzi-Filho

Associated Professor of Pulmonary Division

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vanessa Ieto

Role: PRINCIPAL_INVESTIGATOR

Heart Institute - InCor

Fabiane Kayamori

Role: PRINCIPAL_INVESTIGATOR

Heart Institute - InCor

Geraldo Lorenzi-Filho, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Heart Institute - InCor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Incor- Heart Institute, Sleep Laboratory

São Paulo, São Paulo, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Geraldo Lorenzi-Filho, MD, PhD

Role: CONTACT

55-XX-11-26615486

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Geraldo Lorenzi-Filho, MD, PhD

Role: primary

55 (0xx) 11- 2661-5486

References

Explore related publications, articles, or registry entries linked to this study.

Ieto V, Kayamori F, Montes MI, Hirata RP, Gregorio MG, Alencar AM, Drager LF, Genta PR, Lorenzi-Filho G. Effects of Oropharyngeal Exercises on Snoring: A Randomized Trial. Chest. 2015 Sep;148(3):683-691. doi: 10.1378/chest.14-2953.

Reference Type DERIVED
PMID: 25950418 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3604/11/022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pharmacological Intervention for Symptomatic Snoring
NCT03720353 COMPLETED PHASE1/PHASE2